• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

J VIrol. Crystal structure of the receptor-binding domain from newly emerged Middle East respiratory syndrome coronavirus

Giuseppe

Emeritus
[Source: Journal of Virology, full page: (LINK). Abstract, edited.]


Crystal structure of the receptor-binding domain from newly emerged Middle East respiratory syndrome coronavirus


Yaoqing Chen 1, Kanagalaghatta R. Rajashankar 2, Yang Yang 1, Sudhakar S. Agnihothram 3, Chang Liu 1, Yi-Lun Lin 1, Ralph S. Baric 3 and Fang Li1 *

Author Affiliations: 1 Department of Pharmacology, University of Minnesota Medical School, Minneapolis, MN 55455, USA; 2 Department of Chemistry and Chemical Biology, Cornell University, NE-CAT, Advanced Photon Source, Argonne, IL 60439, USA; 3 Department of Epidemiology, University of North Carolina, Chapel Hill, NC 27559, USA

Published ahead of print 31 July 2013, doi: 10.1128/JVI.01756-13. JVI.01756-13


ABSTRACT

The newly emerged Middle East respiratory syndrome coronavirus (MERS-CoV) has infected at least 77 people with a fatality rate of more than 50%. Alarmingly, the virus demonstrates a capability of human-to-human transmission, raising the possibility of global spread and endangering world health and economy. Here we have identified the receptor-binding domain (RBD) from the MERS-CoV spike protein and determined its crystal structure. This study also presents the structural comparison of MERS-CoV RBD with other coronavirus RBDs, successfully positioning MERS-CoV on the landscape of coronavirus evolution and providing insights into receptor binding by MERS-CoV. Furthermore, we found that MERS-CoV RBD functions as an effective entry inhibitor of MERS-CoV. The identified MERS-CoV RBD may also serve as a potential candidate for MERS-CoV subunit vaccines. Overall, this study enhances our understanding of the evolution of coronavirus RBDs, provides insights into receptor recognition by MERS-CoV, and may help control the transmission of MERS-CoV in humans.


FOOTNOTES

*Correspondence should be sent to: Fang Li, Department of Pharmacology, University of Minnesota Medical School, 6-121 Jackson Hall, 321 Church St SE, Minneapolis, MN 55455, USA, Tel: +1 612-625-6149; Fax: +1 612-625-8408, E-mail: lifang@umn.edu

Copyright ? 2013, American Society for Microbiology. All Rights Reserved.


-
-------
 
Back
Top Bottom